Literature DB >> 32884258

The Effects Study of Isoniazid Conjugated Multi-Wall Carbon Nanotubes Nanofluid on Mycobacterium tuberculosis.

Shahab Zomorodbakhsh1, Yasamin Abbasian2, Maryam Naghinejad3, Mojgan Sheikhpour3,4.   

Abstract

BACKGROUND: Tuberculosis (TB) has always been recognized as one of the fatal infectious diseases, which is caused by Mycobacterium tuberculosis (M.tb). Isonicotinic acid hydrazide or isoniazid (INH) is one of the most commonly utilized drugs in the treatment of TB. Patients need to take 300 mg daily of INH for 6 months in combination with another anti-TB drug and tolerate several side effects of INH. On the other hand, the emergence of resistant strains of anti-TB antibiotics is one of the major problems in the treatment of this disease. So, antimicrobial drug delivery by nanofluids could improve the efficacy, and reduce the adverse effects of antimicrobial drugs. The purpose of this study was to perform a novel method to synthesize INH-conjugated multi-wall carbon nanotubes (MWCNTs) for more effective drug delivery, as well as, TB treatment.
METHODS: INH-conjugated functionalized MWCNTs were prepared, using a reflux system. The characterization of the obtained nano-drug was performed by the elemental analyses of total nitrogen, hydrogen, carbon and sulfur (CHNS), Raman spectroscopy, Fourier transform infrared (FTIR), transmission electron microscopy (TEM), and scanning electron microscopy (SEM) methods. The nanofluid of nano-drug was prepared by the ultrasonic method, and the related antibacterial effect studies were carried out on the two strains of M.tb.
RESULTS: The antimicrobial effect of INH-conjugated MWCNTs was found to be much better at low concentrations than the pure drug in all of the strains.
CONCLUSION: Since one of the main antimicrobial mechanisms of MWCNTs is through the destruction of the bacterial cell wall, in addition to its antimicrobial effects, it increased the drug delivery of INH at lower doses compared to drug alone. So, the nanofluid, containing INH-conjugated MWCNTs, had a better lethal effect on a variety of M.tb strains than that of the drug alone.
© 2020 Zomorodbakhsh et al.

Entities:  

Keywords:  Mycobacterium tuberculosis; isoniazid; multi-wall carbon nanotubes; nano-drug; nanofluid

Mesh:

Substances:

Year:  2020        PMID: 32884258      PMCID: PMC7434524          DOI: 10.2147/IJN.S251524

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  22 in total

1.  Isoniazid-loaded chitosan/carbon nanotubes microspheres promote secondary wound healing of bone tuberculosis.

Authors:  Gangquan Chen; Yaling Wu; Dongping Yu; Rubing Li; Wenyuan Luo; Guifu Ma; Chao Zhang
Journal:  J Biomater Appl       Date:  2018-12-03       Impact factor: 2.646

2.  Fabrication of bioactive rifampicin loaded κ-Car-MA-INH/Nano hydroxyapatite composite for tuberculosis osteomyelitis infected tissue regeneration.

Authors:  Rajendran Amarnath Praphakar; Murugan Sumathra; Rajadas Sam Ebenezer; Sounderrajan Vignesh; Harshavardhan Shakila; Mariappan Rajan
Journal:  Int J Pharm       Date:  2019-05-15       Impact factor: 5.875

3.  Mucoadhesive guargum hydrogel inter-connected chitosan-g-polycaprolactone micelles for rifampicin delivery.

Authors:  Xiaozhi Yuan; Rajendran Amarnath Praphakar; Murugan A Munusamy; Abdullah A Alarfaj; Subbiah Suresh Kumar; Mariappan Rajan
Journal:  Carbohydr Polym       Date:  2018-10-29       Impact factor: 9.381

4.  In vitro combinatory activity of piperine and anti-tuberculosis drugs in Mycobacterium tuberculosis.

Authors:  Laíse Adriane Hegeto; Katiany R Caleffi-Ferracioli; Sandra S Nakamura-Vasconcelos; Aryadne Larissa de Almeida; Vanessa Pietrowski Baldin; Celso Vataru Nakamura; Vera Lúcia D Siqueira; Regiane B L Scodro; Rosilene Fressatti Cardoso
Journal:  Tuberculosis (Edinb)       Date:  2018-05-14       Impact factor: 3.131

5.  Vitamin E TPGS conjugated carbon nanotubes improved efficacy of docetaxel with safety for lung cancer treatment.

Authors:  Rahul Pratap Singh; Gunjan Sharma; Sanjay Singh; Mohan Kumar; Bajarangprasad L Pandey; Biplob Koch; Madaswamy S Muthu
Journal:  Colloids Surf B Biointerfaces       Date:  2016-02-08       Impact factor: 5.268

6.  Antimicrobial activity of CdS and Ag2S quantum dots immobilized on poly(amidoamine) grafted carbon nanotubes.

Authors:  Gururaj M Neelgund; Aderemi Oki; Zhiping Luo
Journal:  Colloids Surf B Biointerfaces       Date:  2012-05-18       Impact factor: 5.268

Review 7.  When tuberculosis treatment fails. A social behavioral account of patient adherence.

Authors:  E Sumartojo
Journal:  Am Rev Respir Dis       Date:  1993-05

8.  Role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model.

Authors:  Shahrzad Tafazoli; Mariam Mashregi; Peter J O'Brien
Journal:  Toxicol Appl Pharmacol       Date:  2008-01-17       Impact factor: 4.219

9.  Development of a biocompatible nanodelivery system for tuberculosis drugs based on isoniazid-Mg/Al layered double hydroxide.

Authors:  Bullo Saifullah; Palanisamy Arulselvan; Mohamed Ezzat El Zowalaty; Sharida Fakurazi; Thomas J Webster; Benjamin M Geilich; Mohd Zobir Hussein
Journal:  Int J Nanomedicine       Date:  2014-10-09

10.  Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014.

Authors:  Basel Karo; Anke Kohlenberg; Vahur Hollo; Raquel Duarte; Lena Fiebig; Sarah Jackson; Cathriona Kearns; Csaba Ködmön; Maria Korzeniewska-Kosela; Dimitrios Papaventsis; Ivan Solovic; Dick van Soolingen; Marieke J van der Werf
Journal:  Euro Surveill       Date:  2019-03
View more
  7 in total

1.  Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages.

Authors:  Anirudh Gairola; Aaron Benjamin; Joshua D Weatherston; Jeffrey D Cirillo; Hung-Jen Wu
Journal:  Adv Ther (Weinh)       Date:  2022-03-09

2.  An effective nano drug delivery and combination therapy for the treatment of Tuberculosis.

Authors:  Mojgan Sheikhpour; Vincent Delorme; Alibakhsh Kasaeian; Vahid Amiri; Morteza Masoumi; Mohammad Sadeghinia; Nayereh Ebrahimzadeh; Mobina Maleki; Shahin Pourazar
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

3.  Modulation of Inflammation-Related Lipid Mediator Pathways by Celastrol During Human Macrophage Polarization.

Authors:  Kehong Zhang; Paul Mike Jordan; Simona Pace; Robert K Hofstetter; Markus Werner; Xinchun Chen; Oliver Werz
Journal:  J Inflamm Res       Date:  2022-06-02

Review 4.  Nanocarrier-Based Approaches for the Efficient Delivery of Anti-Tubercular Drugs and Vaccines for Management of Tuberculosis.

Authors:  Amarjitsing Rajput; Satish Mandlik; Varsha Pokharkar
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

5.  An in Vitro Study of Molecular Effects of a Combination Treatment with Antibiotics and Nanofluid Containing Carbon Nano-tubes on Klebsiella pneumoniae.

Authors:  Maryam Mehdizadeh; Mojgan Sheikhpour; Iman Salahshourifar; Seyed Davar Siadat; Parvaneh Saffarian
Journal:  Iran J Public Health       Date:  2021-11       Impact factor: 1.429

6.  Antibiotic delivery evaluation against Mycobacterium fortuitum using nanofluids containing carbon nanotubes.

Authors:  Hamid Naderi Pargami; Seyed Davar Siadat; Vahid Amiri; Mojgan Sheikhpour
Journal:  BMC Microbiol       Date:  2022-04-11       Impact factor: 3.605

7.  A success targeted nano delivery to lung cancer cells with multi-walled carbon nanotubes conjugated to bromocriptine.

Authors:  Fatemeh Mohammadhosseini Kamazani; Fattah Sotoodehnejad Nematalahi; Seyed Davar Siadat; Majid Pornour; Mojgan Sheikhpour
Journal:  Sci Rep       Date:  2021-12-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.